Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

100%

5 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
4(80.0%)
Phase 3
1(20.0%)
5Total
Phase 4(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06430307Phase 4Not Yet Recruiting

Efficacy and Safety of Saussurea Involucrata Liquid Tonic in Patient With Postpartum Rheumatism

Role: lead

NCT05933486Phase 4Unknown

Efficacy and Safety of Tongluo-Kaibi Tablet in Patients With Fibromyalgia Syndrome

Role: lead

NCT05913310Phase 4Unknown

Efficacy and Safety of Kui-Yuan Chewable Tablets in Patients With Hyperuricemia

Role: lead

NCT05393050Phase 4Unknown

Efficacy and Safety of Colquhounia Root Tablet in Patients With Rheumatoid Arthritis

Role: lead

NCT02674776Phase 3Unknown

Efficacy and Safety of HuZhen Capsule for Treatment of Patients With Acute Gout

Role: lead

All 5 trials loaded